SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10694557
Source:
http://linkedlifedata.com/resource/pubmed/id/10694557
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0007097
,
umls-concept:C0008838
,
umls-concept:C0144576
,
umls-concept:C0205179
,
umls-concept:C0227598
,
umls-concept:C0282460
,
umls-concept:C1512162
,
umls-concept:C2603343
pubmed:issue
5
pubmed:dateCreated
2000-3-24
pubmed:abstractText
Cisplatin and paclitaxel are active agents in advanced urothelial cancer. A phase II trial of this combination was performed to determine the activity and toxicity of these agents in a multi-institutional setting.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA21076
,
http://linkedlifedata.com/resource/pubmed/grant/CA23318
,
http://linkedlifedata.com/resource/pubmed/grant/CA49883
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0732-183X
pubmed:author
pubmed-author:CohenM BMB
,
pubmed-author:DreicerRR
,
pubmed-author:HatfieldA KAK
,
pubmed-author:ManoliRR
,
pubmed-author:RothB JBJ
,
pubmed-author:WildingGG
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1058-61
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10694557-Adult
,
pubmed-meshheading:10694557-Aged
,
pubmed-meshheading:10694557-Aged, 80 and over
,
pubmed-meshheading:10694557-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:10694557-Carcinoma, Transitional Cell
,
pubmed-meshheading:10694557-Cisplatin
,
pubmed-meshheading:10694557-Female
,
pubmed-meshheading:10694557-Humans
,
pubmed-meshheading:10694557-Male
,
pubmed-meshheading:10694557-Middle Aged
,
pubmed-meshheading:10694557-Paclitaxel
,
pubmed-meshheading:10694557-Treatment Outcome
,
pubmed-meshheading:10694557-Urologic Neoplasms
,
pubmed-meshheading:10694557-Urothelium
pubmed:year
2000
pubmed:articleTitle
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study.
pubmed:affiliation
Departments of Hematology/Oncology and Urology, The Cleveland Clinic Foundation, Cleveland, OH, USA. dreicer@ccf.org
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Clinical Trial, Phase II